- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05076669
Quality of Life Impact After Enhanced Follow-up of Ostomy Patients (StomaCare)
Quality of Life Impact After Enhanced Follow-up of Ostomy Patients by a Home Healthcare Nursing Service Employing Stomal Therapy Nurse Consultants Compared to Conventional Care
In this context, FSK would like to implement a clinical study to assess the added value on the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including stomal therapists.
The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.
The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
France currently has about 80,000 ostomy patients. Stoma placement exposes patients to many surgical or peristomal skin complications which could impair the quality of life of the ostomy patient.
The management of ostomy patients varies from institution to institution and according to how the patient's medical equipment is supplied as well as whether or not specialised personnel are available.
In the last decade, the market for stoma therapy in France has evolved, with a significant increase in the delivery of equipment by HHNs, meeting a need for patient follow-up and accompaniment.
This increased preference of HHNs to use specialist nurses seems to be explained by the added benefits. Early international studies have demonstrated the impact of an enterostomal therapy nurse follow-up on the improvement of ostomy patient's quality of life (QoL) relative to their health.
However, none of the studies available today on follow-ups performed by an enterostomal therapist included the French population. Furthermore, the studies show methodological gaps, a limited time span and are based on strong hypotheses.
In this context, FSK would like to implement a clinical study to assess the added value on the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including stomal therapists.
The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.
The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Le Kremlin-Bicêtre, Frankrijk, 93043
- Hôpital Bicêtre
-
Lyon, Frankrijk
- Hôpital Lyon-Sud
-
Paris, Frankrijk, 75012
- Hôpital Saint-Antoine
-
Paris, Frankrijk, 75013
- Hôpital de la Pitié-Salpétrière
-
Paris, Frankrijk, 75009
- Hopital Saint Louis
-
Paris, Frankrijk, 75009
- Hôpital Saint-Louis
-
Paris, Frankrijk, 75015
- Hopital HEGP
-
Suresnes, Frankrijk
- ESPIC FOCH - Digestige Unit
-
Suresnes, Frankrijk
- ESPIC Foch - Urology Unit
-
Toulouse, Frankrijk
- CHU Toulouse
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Male or female ≥ 18 years
- Patients with a stoma placed less than 10 days ago
- Patients who had a stoma during their current hospitalisation
- Patients informed verbally and in writing via the information sheet and who signed the informed consent form.
Exclusion Criteria:
- Patients in palliative care
- Patients participating in another clinical study interested in the management of ostomy patients
- Patients not enrolled in a social security system or with the CMU (Couverture maladie universelle [Universal Health Coverage])
- Patients under judicial protection or under guardianship
- Patients deprived of freedom (in prison and psychiatric patients being treated without consent)
- Patients with difficulties understanding or reading French
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Actieve vergelijker: Control
The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.
|
routine management of stoma
|
Experimenteel: interventional group
The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.
|
delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Efficacy
Tijdsspanne: 3 months
|
score from the Stoma-QOL specific questionnaire (min: 0- max: 100), analysis of the mean
|
3 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Satisfaction of patient
Tijdsspanne: 3 and 6 months
|
scale 0-100
|
3 and 6 months
|
Quality of life
Tijdsspanne: 1, 2, 3 and 6 months
|
Stoma-QOL questionnaire, (min: 0- max: 100), analysis of the mean
|
1, 2, 3 and 6 months
|
Quality of life
Tijdsspanne: 1, 2, 3 and 6 months
|
EQ-5D-5L questionnaire (min: 0- max: 1), analysis of the mean
|
1, 2, 3 and 6 months
|
Cost
Tijdsspanne: 3 and 6 months
|
• Calculation of resource use at 3 and 6 months per expenditure item (use of services, drug use, medical device and home healthcare service use, MCO (Médecine chirurgie obstétrique [Obstetric surgery]) hospitalisations and SSR (Soins de suite et de réadaptation [Follow-up care and rehabilitation]) hospitalisations) for each group.
|
3 and 6 months
|
Morbidity
Tijdsspanne: 3 and 6 months
|
readmission rate
|
3 and 6 months
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Persson E, Berndtsson I, Carlsson E, Hallen AM, Lindholm E. Stoma-related complications and stoma size - a 2-year follow up. Colorectal Dis. 2010 Oct;12(10):971-6. doi: 10.1111/j.1463-1318.2009.01941.x.
- Neil N, Inglese G, Manson A, Townshend A. A Cost-Utility Model of Care for Peristomal Skin Complications. J Wound Ostomy Continence Nurs. 2016 Jan-Feb;43(1):62-8. doi: 10.1097/WON.0000000000000194.
- Marquis P, Marrel A, Jambon B. Quality of life in patients with stomas: the Montreux Study. Ostomy Wound Manage. 2003 Feb;49(2):48-55.
- Danielsen AK, Rosenberg J. Health related quality of life may increase when patients with a stoma attend patient education--a case-control study. PLoS One. 2014 Mar 7;9(3):e90354. doi: 10.1371/journal.pone.0090354. eCollection 2014.
- Becker A, Schulten-Oberborsch G, Beck U, Vestweber KH. Stoma care nurses: good value for money? World J Surg. 1999 Jul;23(7):638-42; discussion 642-3. doi: 10.1007/pl00012361.
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Verwacht)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- FSK-001
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Kwaliteit van het leven
-
Rambam Health Care CampusOnbekendom LIF-niveau in navelstrengbloed van embryo's die IUGR zijn te vergelijken met degenen die AGA zijn
Klinische onderzoeken op standard of care
-
Compedica IncProfessional Education and Research InstituteWervingDiabetische voetzweerVerenigde Staten, Canada
-
NYU Langone HealthVoltooidMultiple scleroseVerenigde Staten
-
Brian W. NoehrenU.S. Army Medical Research and Development CommandWervingFemorale breuk | Tibiale fracturenVerenigde Staten
-
Medical University of South CarolinaIcahn School of Medicine at Mount SinaiVoltooidIschemische cerebrovasculair accidentVerenigde Staten
-
OrganogenesisVoltooidVeneuze zweerVerenigde Staten
-
Coloplast A/SBeëindigdHuid conditie | LekkageDenemarken, Frankrijk, Duitsland, IJsland
-
Nohla Therapeutics, Inc.BeëindigdLeukemie, myeloïde, acuutVerenigde Staten, Korea, republiek van, Australië
-
Hospital Universitario Ramon y CajalOnbekendCardiogene shockSpanje
-
Occlutech International ABWervingHartinfarct | Octrooi Foramen OvaleVerenigde Staten, Denemarken, Canada, Nederland, Duitsland, Verenigd Koninkrijk, Finland
-
Integra LifeSciences CorporationIntegriumBeëindigdDiabetische voetzwerenVerenigde Staten, Puerto Rico, Canada, Zuid-Afrika